HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Dik J Kwekkeboom Selected Research

Dik J Kwekkeboom Research Topics

Disease

28Neoplasms (Cancer)
11/2015 - 04/2002
24Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2016 - 04/2002
8Neoplasm Metastasis (Metastasis)
09/2012 - 04/2004
4Thyroid Neoplasms (Thyroid Cancer)
01/2007 - 04/2004
3Pituitary Neoplasms (Pituitary Adenoma)
04/2007 - 12/2003
2Sarcoidosis (Schaumann Disease)
12/2015 - 11/2011
2Thrombocytopenia (Thrombopenia)
12/2013 - 03/2010
2Pheochromocytoma
04/2008 - 01/2007
2Carcinoma (Carcinomatosis)
04/2008 - 04/2004
2Carcinoid Tumor (Carcinoid)
04/2008 - 08/2007
2Breast Neoplasms (Breast Cancer)
04/2004 - 04/2003
1Granuloma
12/2015
1Insulinoma
01/2015
1Hypercalcemia (Milk Alkali Syndrome)
09/2014
1Hyperglycemia
12/2013
1Fatigue
12/2013
1Vipoma (WDHA)
04/2008
1Diarrhea
04/2008
1Paraganglioma (Paragangliomas)
01/2007
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2007
1Renal Insufficiency (Renal Failure)
01/2007
1Cicatrix (Scar)
01/2006
1Fibrosis (Cirrhosis)
01/2005
1Necrosis
01/2005
1Melanoma (Melanoma, Malignant)
12/2003
1Hodgkin Disease (Hodgkin's Disease)
04/2003

Drug/Important Bio-Agent (IBA)

20Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2015 - 04/2002
19Somatostatin Receptors (Somatostatin Receptor)IBA
12/2015 - 04/2002
15Peptide Receptors (Peptide Receptor)IBA
02/2016 - 04/2003
9Tyr(3)- octreotateIBA
11/2015 - 04/2002
8Octreotide (Sandostatin)FDA LinkGeneric
09/2012 - 04/2002
7Pentetic Acid (DTPA)FDA LinkGeneric
09/2012 - 04/2002
5Radioisotopes (Radionuclides)IBA
06/2012 - 04/2002
53-Tyr-octreotideIBA
03/2010 - 04/2002
4yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
03/2010 - 01/2005
3pentetreotide (OctreoScan)FDA Link
05/2010 - 04/2003
3BombesinIBA
07/2009 - 12/2002
3Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
07/2009 - 04/2008
3Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2007 - 12/2003
2HormonesIBA
09/2010 - 04/2008
2PeptidesIBA
05/2010 - 07/2009
2indium-111-octreotideIBA
07/2009 - 01/2005
1glucagon-like peptide receptor (receptor, glucagon-like peptide)IBA
01/2015
1Parathyroid Hormone-Related ProteinIBA
09/2014
1everolimusFDA Link
12/2013
1Alanine Transaminase (SGPT)IBA
12/2013
1adalimumab (Humira)FDA Link
11/2011
1Chromogranin AIBA
09/2011
1thymidine 5'-triphosphate (TTP)IBA
03/2010
1Substance PIBA
07/2009
1Cholecystokinin (Pancreozymin)IBA
07/2009
1NeuropeptidesIBA
07/2009
1GastrinsIBA
07/2009
1RadiopharmaceuticalsIBA
07/2009
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
04/2008
1SynaptophysinIBA
04/2008
1Dopamine Receptors (Dopamine Receptor)IBA
04/2007
1Protective AgentsIBA
01/2007
1InterferonsIBA
04/2006
1LutetiumIBA
01/2006
1YttriumIBA
01/2006
1papillary Thyroid cancerIBA
01/2005
1follicular Thyroid cancerIBA
01/2005
1hexamminecobalt(III) tricarbonatocobaltate(III)IBA
01/2005
1Factor IX (PTC)FDA LinkGeneric
01/2005
1minigastrinIBA
04/2004
1Cholecystokinin B ReceptorIBA
04/2004
1BenzamidesIBA
12/2003
1benzamideIBA
12/2003
1Uveal melanomaIBA
12/2003
1Gastrin-Releasing PeptideIBA
12/2002

Therapy/Procedure

5Aftercare (After-Treatment)
10/2013 - 01/2005
4Radiotherapy
09/2010 - 12/2002
3Drug Therapy (Chemotherapy)
07/2009 - 01/2005
1Neoadjuvant Therapy
11/2015
1Salvage Therapy
03/2010